ADEN/SANAA — Yemen’s drug problem is no longer a footnote to its war. It is becoming one of the war’s central economic and social dynamics. In the first quarter of 2026 alone, security forces in government-controlled areas arrested 337 drug suspects and seized over 1.1 million Captagon pills, 609 kilograms of methamphetamine, 100 kilograms of heroin, and 576 kilograms of hashish . In late October, a raid in Hadramout uncovered eight tons of hashish, Captagon, and Tramadol alongside explosives and counterfeit currency . And at the Al-Wadiah border crossing with Saudi Arabia, foiled smuggling attempts have become routine—4,925 Captagon pills in February, then 203 pills, 795 Tramadol capsules, and over three kilograms of opium in July, hidden inside a disguised fire extinguisher .
The numbers tell a story of a country being transformed from a transit route into a production and consumption hub. A study by the Mokha Center for Strategic Studies, reported by Al-Hal Net, concludes that Yemen has become “an active environment for the production, manufacture and redistribution of narcotics, after previously serving only as a transit route” . The implications for a society already shattered by eleven years of war are severe.
The Houthi Economy of Narcotics
The most politically consequential dimension of Yemen’s drug trade is the allegation—repeated by government officials, security sources, and independent research—that the Houthi movement is not merely tolerating trafficking but managing it. The Mokha Center study states that the drug trade is “no longer in the hands of traditional mafia networks, but is now run under the direct supervision of Houthi leaders, as part of a financial network that depends on extortion, levies and illicit activity” .
Brigadier General Abdullah Ahmed Lahmadi, director of Yemen’s General Department for Drug Control, was explicit in April: “The Houthi terrorist militia, with support from the Iranian regime, stands behind many of the smuggling and drug trafficking operations, as a source of funding for its wars and a tool to destroy societies and destabilize security and stability in Yemen and the Arab region” . The Al-Wadiah border battalion has stated that preliminary investigations indicate most drug shipments seized at the crossing originate from Houthi-controlled areas .
The study identifies specific mechanisms. Drug shipments arrive through seaports and are moved along overland routes through Saada province, which has become a major transit point toward Saudi Arabia. Pharmaceutical companies and pharmacies are used as fronts, with forged permits ensuring the flow of substances beyond regulatory oversight . Perhaps most disturbing is the claim that some substances are used inside military camps “to reduce fighters’ fear and increase their aggression, as a tool to regulate and control their behavior” .
The Houthis have not responded publicly to these specific allegations. But the pattern of seizures—at the Saudi border, in Hadramout, in Lahj—is consistent with an organized trade rather than isolated criminality.
Captagon, Tramadol, and the Pharmacies
The substances flowing through Yemen reflect both regional trafficking patterns and local vulnerabilities. Captagon, an amphetamine-type stimulant manufactured primarily in Syria and Lebanon, is the dominant smuggled pill, destined largely for Saudi Arabia and the Gulf. The February seizure in Lahj—450 bags containing 1,000 pills each, intercepted on a boat off the coast of Al-Madaribah—was described as one of the largest ever recorded in the region .
Tramadol, a synthetic opioid analgesic, occupies a different niche. It is legally available in Yemen only with official permits and medical supervision, but it is widely smuggled and abused. In October, security forces in Aden’s Al-Buraiqah district found 11,000 Tramadol ampoules hidden beneath a truck . Dr. Salah Saif of the Aden Security Belt’s health unit warned that taking the drug without medical guidance “may lead to physiological habituation and then psychological dependence—that is, addiction—and many neurological diseases” .
The Ministry of Public Health has acknowledged that some pharmaceutical substances, including Pregabalin and Tramadol, are being exploited through forged prescriptions and counterfeit stamps. Dr. Anis Mahdar, director of pharmaceutical control, said the ministry is working with security agencies and the prosecution to prepare a 2026 work charter to strengthen oversight and pursue smuggling and promotion networks. He stressed that “whoever falls victim to abuse is a patient who needs treatment and care, not stigmatization or exclusion” .
The Treatment Gap
That principle is difficult to honor in a country where treatment infrastructure barely exists. A report by Aden Al-Ghad described the case of a young man whose friend, “known for his morals and good conduct,” slid into addiction after severe family pressures. The friend expressed a genuine desire to quit but faced “great difficulty due to the absence of job opportunities, deadly idleness, and fear of withdrawal symptoms that prevent him from taking the step of treatment without specialized medical supervision.” The report noted growing community demands for a government-run addiction treatment hospital in Aden, warning that “addiction is no longer just individual behavior, but a societal issue requiring urgent intervention” .
Yemen’s health system, decimated by war, has neither the facilities nor the trained personnel to address addiction at scale. The National AIDS Program remains severely underfunded and excluded from humanitarian funding frameworks, and the broader health infrastructure is focused on primary care and maternal and child health—critical priorities, but ones that leave substance use disorders unaddressed .
A Society Under Siege
The social consequences of the drug trade extend beyond individual addiction. The Mokha Center study points to rising addiction rates, the breakdown of many families, and “the emergence of forms of violence previously unfamiliar in Yemen” . Reports also speak of drugs being used in recruitment efforts, particularly among young people, raising concerns about long-term effects on a generation already shaped by war .
Yemen’s drug problem is inseparable from its conflict economy. The war created the conditions—weak institutions, fragmented authority, desperate poverty, and armed groups seeking revenue—in which trafficking flourishes. The Houthis’ alleged role in managing the trade is both a symptom of that economy and a driver of it. And the government’s counter-narcotics efforts, while producing impressive seizure statistics, are fighting a battle against networks that operate across borders, through ports, and with the protection of armed power.
For the young man in Aden who wants to quit but cannot find a hospital, and for the families watching addiction consume their children, the war’s newest front is being fought not with missiles but with pills. The seizures will continue. The arrests will be announced. But without treatment, without economic opportunity, and without an end to the conflict that feeds the trade, Yemen’s drug crisis will only deepen.
